检索

标题
作者
Experience of using the interleukin-17A inhibitor secukinumab in the treatment of psoriasis and psoriatic arthritis
Molochkova Y., Petrova M., Molochkov V., Monaenkova M., Abalukhova E.
Pathogenesis of psoriasis: past, present, future
Kandalova O., Klyuchnikova D., Ayvazova T.
The effectiveness of the IL-17A inhibitor in generalized pustular psoriasis: a clinical case
Olisova O., Snarskaya E., Kochergin N., Teplyuk N., Ignatyev D., Tavitova A., Makhmudi W.
Impact of combination therapy on Ki-67 and Bcl-2 expression in psoriasis
Melikova N., Tashkenbaeva U.
Metabolic screening as a tool for assessing the pathogenesis and course of psoriasis
Olisova O., Kukes V., Kukes I., Ignatiev D., Rogacheva V.
On the issue of tolerability and safety of phototherapy in patients with psoriasis
Olisova O., Grekova E., Smirnov K., Yazkova O., Koriakin D., Melikova N.
Efficacy and safety of PUVA and UVB-311 nm in psoriasis: single-center retrospective study
Yazkova O., Anpilogova E.
Psychosomatic aspects of psoriasis (review)
Dorozhenok I., Ilina E.
Efficacy and safety of early treatment of patients with skin psoriasis and axial arthritis with IL-17 inhibitors
Pereverzina N., Kruglova L., Korotaeva T.
The role of Vitamin D in the pathogenesis of some immune-mediated dermatoses
Pritulo O., Brodavkin D., Ravlyuk D., Bekirova E., Petrov A.
IL-17A in the treatment of nail psoriasis
Olisova O., Nikuradze V., Koroleva M.
Effect of phototherapy on psychoemotional state in psoriasis: assessment of depression, anxiety and quality of life
Yazkova O., Olisova O., Anpilogova E.
Clinical case of psoriasis in an HIV-positive patient
Kleymenova V., Krinitsyna Y., Pakhomova V.
Relationship between the level of vitamin D in bloof flow and skin dermatosis
Morozova E., Kurdyukova E.
Data dynamics of angiogenesis visualization instrumental methods in patients with psoriasis during methotrexate therapy: Clinical and prognostic value of dermatoscopy and ultrasound dopplerography
Pritulo O., Petrov A., Brodavkin D.
Randomized study of the efficacy of monoclonal antibodies in patients with refractory psoriasis
Olisova O., Nikuradze V., Grekova E.
Psoriatic onychodystrophy: Clinical course, diagnosis and therapeutic aspects
Taganov A., Molochkov A., Kulikova N., Ali Mohammad A., Monaenkova M., Zaslavsky D., Kozlova D.
Effect of psoriasis on cardiovascular risk
Kuzmina O., Mironova O., Lepekhova A., Tregub K., Demin A., Fomin V., Olisova O.
Clinical significance of plasma markers of angiogenesis in patients with psoriasis
Pritulo O., Petrov A., Maraqa M.
Biological therapy of psoriasis in the era of COVID-19: discussing the risks and benefits
Pritulo O., Rychkova I., Maraqa N.
Resistin in patients with psoriasis vulgaris during PUVA therapy
Yatskova O., Teplyakova K., Pritulo O.
Prevalence and clinical signs of inflammatory back pain in patients with skin psoriasis and axial involvement
Pereverzina N., Kruglova L., Korotaeva T.
Clinical and epidemiological features of psoriasis in the Republic of Uzbekistan
Olisova O., Melikova N., Tashkenbaeva U., Torchinskiy N.
Phototherapy for psoriasis
Yazkova O., Anpilogova E.
COVID-19-induced alopecia: a clinical case of diffuse focal alopecia in a patient with generalized pustular psoriasis after a new coronavirus infection
Petrova M., Kartashova M., Molochkova Y., Molochkov A., Varfolomeev A.
Transcranial stimulation physiotherapy for psoriasis
Utz S., Raigorodsky Y., Zuev A.
Pustular psoriasis and arthropathy in a patient with HIV infection. Clinical case
Dubensky V., Nekrasova E., Dubensky V., Alexandrova O., Muraveva E.
Diagnostic algorithm for psoriatic arthritis in clinical practice of dermatologist
Chamurlieva M., Korotaeva T., Loginova E., Batkaev E.
Psoriasis in a patient with ichthyosis
Tlish M., Katkhanova O., Naatyzh Z., Popovskaya E., Sycheva N.
Prevalence and etiology of onychomycosis in patients with psoriasis: a single-center study
Kochergin N., Maximov I.
THE CASE OF PSORIATIC ERYTHRODERMA AND SEVERE COMORBID PSORIATIC ARTHRITIS
Olisova O., Kochergin N., Belousova T., Nikuradze V., Gudova V.
INCIDENCE OF PSORIASIS DEPENDING ON THE REGION OF THE RUSSIAN FEDERATION
Gudinova Z., Okhlopkov V., Poleshchuk E., Zhernakova G.
Study of the effect of menopausal hormone therapy in women with psoriasis type 2 in postmenopause
Opruzhenkova E., Sidorenko O., Anisimova L., Starostenko V.
The flaws of total systems therapy with biological preparations in psoriasis
Sokolovskiy E., Kruglova L., Ponich E.
Combined therapy of patients with psoriasis
Degtyarev O., Dumchenko V., Tkachenko T., Zhizhimova O., Bakhmutova E., Selivanova I., Erina I.
CLINICAL AND LABORATORY CHARACTERISTICS OF PSORIASIS ASSOCIATED WITH HORMONAL METABOLIC DISORDERS
Perlamutrov Y., Mikryukov A.
Morphofunctional changes in the skin in topical tacrolimus therapy of localized psoriasis
Olisova O., Tkachenko S., Keskin G.
THE ROLE OF CD45RA+, CD45RO+ LYMPHOCYTES IN THE PATHOGENESIS OF PSORIASIS
Khairutdinov V., Mikhailichenko A., Piskunova A., Mukhina M., Tarasenko G., Samtsov A.
Kliniko-immunologicheskie izmeneniya pri lechenii psoriaza infliksimabom
Kurdina M., Makarenko L., Polyanskaya A.
Methotrexate in psoriasis treatment: a single-center retrospective study (2018–2020)
Olisova O., Anpilogova E.
PSORIASIS VS MALIGNANCIES: POSSIBLE INTERRELATION AND POTENTIAL RISKS
Osina A., Ponich E., Kruglova L.
USE OF AUTOLOGOUS PLATELET-RICH PLASMA WITH THROMBOCYTES IN DERMATOCOSMETOLOGY (REVIEW)
Karagadyan A.
General cryotherapy with the use of cryocapsule ICEQUEEN in patients with various dermatoses
Olisova O., Kayumova L., Smirnov K., Shuppo O., Arsentyev N.
Psychoneurological characteristics of psoriasis patients
Dontsova E.
Phototherapy for psoriasis: Basic mechanisms of action
Zhilova M., Volnukhin V.
Merkel cell carcinoma in psoriasis vulgaris
Pravdina O., Vodolazskiy V., Reznikov A., Okhlopkov V.
ANTICYTOKINE THERAPY FOR SEVERE PSORIASIS FORMS
Tarasenko G., Belyakin S., Ryzhman N., Kuzmina Y.
A CASE WITH ANDOGSKY’S SYNDROME CONCOMITANT WITH PSORIASIS
Sukhova T., Molochkov V., Snarskaya E., Makarova E., Ryabtseva A., Belova T., Androkhina O.
Kliniko-patogeneticheskoe znachenie i korrektsiya immunologicheskikh narusheniy u bol'nykh s deskvamativnymi porazheniyami kozhi (soobshchenie 2)
Polesko I., Butov Y., Malinovskaya V., Anikhovskaya I.
Biological drugs prescription issues in terms of the new coronaviral infection COVID-19 pandemic. Literature review and clinical case
Kruglova L., Shatokhina E., Polonskaya A.
Evaluation of subpopulations of T lymphocytes in psoriasis patients during therapy
Kochergin N., Paramonov A., Kayumova L.
PSORIASIS ADJUVANT THERAPY
Bakulev A., Krachevnya S., Igonina I., Galkina E., Utz S.
Comorbidities in psoriasis
Olisova O., Garanyan L.
The IL-36y is potential biomarker of psoriatic erythroderma
Zaslavsky D., Sydikov A., Chuprov I., Ibragimov K., Nasyrov R., Egorova Y., Khvedelidze M., Wenzel J.
Effects of combined therapy on the time course of the articular syndrome in patients with psoriasis in the presence of lipid metabolism disorders
Yakubovich A., Saldamaeva L.
Topical therapy for scalp: from traditions to innovations
Snarskaya E.
Toll receptor 4 and 9 gene polymorphisms in patients with psoriasis
Okhlopkov V., Novikov A., Kononov A., Pomorgailo E., Petrova E., Pravdina O.
Experience of treatment of psoriasis with Skin-cap
Sergeeva V., Sergeyeva V.
Ul'trazvukovoy monitoring psoriaza
Kurdina M., Makarenko L., Markina N., Nasnikova I.
Evaluation of the effectiveness of long-term interruption and resumption of therapy with ustekinumab in psoriasis patients with metabolic disorders
Rychkova I., Pritulo O., Maraqa M., Babanin V.
Regulatory T cells, CD4+CD25+FOXР3+CD127LOW, in patients with vulgar psoriasis
Olisova O., Bykovskaia S., Gudova V.
PSORIASIS IN PATIENT WITH VITILIGO
Dubensky V., Nekrasova E., Muraveva E., Alexandrova O., Gutyanskaya E.
Melanocortin 1 receptor MC1R as a genetic factor in the development of psoriasis
Galimova E., Kõks S., Kingo K., Khusnutdinova E.
T-cell receptor repertory in some immunassociated dermatoses
Paramonov A., Kayumova L., Bruskin S., Kochergin N., Olisova O., Ostretsova M.
Dysproteinemia: A factor of psoriasis pathogenesis
Degtyarev O., Mesnyankina O.
EVALUATION OF THE SOMATIC, PSYCHOLOGICAL, AND SOCIAL COMPONENTS OF THE QUALITY OF LIFE IN PATIENTS WITH PSORIASIS
Kashutin S., Bondarenko M., Danilov S., Klyuchareva S.
EXPRESSION OF MATRIX METALLOPROTEASES IN PSORIASIS AND ATHEROSCLEROSIS
Sautin M., Soboleva A., Zolotarenko A., Piruzyan E., Korsunskaya I., Orekhov P., Chupin A., Bruskin S., Sobolev V.
CLINICAL EFFICIENCY OF PSORIASIS TREATMENT USING CRYOTHERAPY
Vasenova V., Butov Y., Akhtyamov S., Karpova A.
Clinical efficacy and characteristics of immunological changes in patients with psoriasis following the combined use of sulfide peloids from Lake Saki
Kuznetsova M., Pritulo O., Dovgan I., Sokolova O.
Genodermatoses in Primorye territory: clinical heterogeneity of Werner syndrome
Yutskovskiy A., Yutskovskaya Y., Stupin A., Fedorova E., Kulagina L., Koval'chuk E., Yutskovskiy A., Yutskovskaya Y., Stupin A., Fedorova E., Kulagina L., Kovalchuk E.
PSORIASIS IN HIV-INFECTED PATIENTS: CLINICAL AND LABORATORY EVALUATION, APPROACHES TO THERAPY
Evdokimov E., Sundukov A.
Topical treatment of chronic dermatoses with kertoplastic agents
Grabovskaya O., Vertieva E., Shestakova L., Grekova E.
Pulsed mesotherapy of immunoassociated dermatoses
Zavadsky V.
GENE METHYLATION IN CD3+ CELLS IN PSORIASIS
Sobolev V., Denisova E., Soboleva A., Korsunskaya I., Chekalin E., Zolotarenko A., Bruskin S.
The role of immune cells and cytokines in the development of psoriasis
Pinegin B., Ivanov O., Pinegin V.
EFFERENT QUANTUM METHODS IN MULTIPLE MODALITY TREATMENT OF PSORIASIS
Baityakov V., Filimonkova N.
EVALUATION OF THE EFFECTIVENESS OF TOPICAL TREATMENT COMBINATION OF BETAMETHASONE DIPROPIONATE 0.05%/CALCIPOTRIOL MONOHYDRATE 0.005% GEL AND CLOBETASOLE PROPIONATE 0.05% OINTMENT IN PATIENTS WITH PSORIATIC ONYCHODYSTROPHY
Maximov I., Kochergin N., Novoselov V., Ushakova D.
Correction of lipid metabolism disorders in patients with psoriasis
Yakubovich A., Saldamaeva L., Novoselov V., Novitskaya N., Novoselov A., Yakubovich A., Saldamayeva L., Novoselov V., Novitskaya N., Novoselov A.
THE USE OF TOFACITINIB FOR TREATMENT PATIENTS WITH PSORIASIS IN CONDITIONS OF THE DERMATOLOGICAL HOSPITAL
Natarova E., Rudneva N., Kuklina M., Chumakova Y.
Clovate therapy of steroid-sensitive dermatoses
Snarskaya E., Shnakhova L.
CHANGES IN THE LEVELS OF MOLECULES MEDIATING LYMPHOCYTE MIGRATION TO THE SKIN IN PSORIASIS PATIENTS
Belonogov R., Ruksha T.
ADALIMUMAB IN PSORIASIS: OUR FIRST EXPERIENCE
Kochergin N., Potekayev N., Smirnova L., Serov D., Olisova O., Babushkin A.
Comparative effectiveness of narrow-band 311 nm UVB therapy of psoriasis
Olisova O., Vladimirov V., Smirnov K., Talybova A., Olisova O., Vladimirov V., Smirnov K., Talybova A.
Pharmacogenetic approach to methotrexate-related toxicity prediction in psoriasis
Kubanov A., Asoskova A., Sychev D.
EFFICACY OF NARROWBAND ULTRAVIOLET B 311 NM PLUS AN INHIBITOR OF PHOSPHODIESTERASE 4 (PDE4) COMBINED THERAPY IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Olisova O., Grekova E., Svistunova D.
OVERVIEW OF MODERN STUDIES OF COMORBIDITY IN PSORIASIS
Pashinyan A., Dontsova E.
EPIDEMIOLOGY, ETIOPATHOGENESIS, COMORBIDITY IN PSORIASIS - NEW FACTS
Olisova O., Garanyan L.
Sluchay sochetaniya mnozhestvennogo pyatnistogo nevusa s psoriazom
Molochkov V., Bagapsh L., Novoselova N.
Potentialities of liposomal cosmetics in therapy for psoriasis
Khlebnikova A., Molochkov A.
Cyclosporine A in dermatology
Garanyan L., Avagyan D.
ISIDA LIPOSOMAL LINE FOR COMPLEX CARE OF COMBINED AND FAT SKIN
Snarskaya E., Surikova N., Chubatova S.
ACUTE PHASE PROTEINS IN THE SERA OF PSORIASIS PATIENTS
Shkolnikova T., Zorina V., Korotky N., Zorina R., Burdina A., Konyakhina I.
Innovative liposomal preparations "Aycida" and their use in dermatocosmetology
Snarskaya E., Kryazheva S., Snarskaya Е., Kryazheva S.
Evolution of biological therapy for psoriasis: realities and prospects
Fayzullina E., Marsina A., Khismatulina I., Zinatulina G.
SECUKINUMAB FOR TREATMENT OF PATIENTS WITH REFRACTORY PSORIASIS
Olisova O., Nikuradze V.
PATHOGENIC ROLE OF CYTOKINES IN PSORIASIS
Karapetyan S., Khachikyan K.
EXPERIENCE OF THE LONG-TERM USE OF ANTICYTOKINE THERAPY IN PSORIASIS
Kovtunova V., Dumchenko V., Bakhmutova E., Tkachenko T., Yanchevskaya E., Mesnyankina O.
Melatonin preparations in dermatological practice
Garanyan L.
Pathogenetic role of lipid profile disorders in psoriasis
Degtyarev O., Mesnyankina O.
TACROLIMUS IN THE TREATMENT OF DIFFERENT SKIN DISEASES
Olisova O., Kochergin N., Murakhovskaya E., Keskin G., Olisov A., Davidovich M., Garanyan L., Shurubei V.
1 - 100 的 103 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##